These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
252 related items for PubMed ID: 29451067
1. Combined detection of uMCP-1 and uTWEAK for rapid discrimination of severe lupus nephritis. Dong XW, Zheng ZH, Ding J, Luo X, Li ZQ, Li Y, Rong MY, Fu YL, Shi JH, Yu LC, Wu ZB, Zhu P. Lupus; 2018 May; 27(6):971-981. PubMed ID: 29451067 [Abstract] [Full Text] [Related]
2. Combined utilization of untimed single urine of MCP-1 and TWEAK as a potential indicator for proteinuria in lupus nephritis: A case-control study. Dong X, Zheng Z, Luo X, Ding J, Li Y, Li Z, Li S, Rong M, Fu Y, Wu Z, Zhu P. Medicine (Baltimore); 2018 Apr; 97(16):e0343. PubMed ID: 29668584 [Abstract] [Full Text] [Related]
3. Urinary Tumor Necrosis Factor-Like Weak Inducer of Apoptosis (uTWEAK) and Urinary Monocyte Chemo-attractant Protein-1 (uMCP-1): Promising Biomarkers of Lupus Nephritis Activity? Elsaid DS, Abdel Noor RA, Shalaby KA, Haroun RA. Saudi J Kidney Dis Transpl; 2021 Apr; 32(1):19-29. PubMed ID: 34145111 [Abstract] [Full Text] [Related]
4. Urinary MCP-1 and TWEAK as non-invasive markers of disease activity and treatment response in patients with lupus nephritis in South Africa. Moloi MW, Rusch JA, Omar F, Ekrikpo U, Dandara C, Bello AK, Jayne D, Okpechi IG. Int Urol Nephrol; 2021 Sep; 53(9):1865-1873. PubMed ID: 33459955 [Abstract] [Full Text] [Related]
5. Assessment of urinary TWEAK levels in Mexican patients with untreated lupus nephritis: An exploratory study. Reyes-Martínez F, Pérez-Navarro M, Rodríguez-Matías A, Soto-Abraham V, Gutierrez-Reyes G, Medina-Avila Z, Valdez-Ortiz R. Nefrologia (Engl Ed); 2018 Sep; 38(2):152-160. PubMed ID: 28755900 [Abstract] [Full Text] [Related]
6. Soluble TNF-R1, VEGF and other cytokines as markers of disease activity in systemic lupus erythematosus and lupus nephritis. Adhya Z, El Anbari M, Anwar S, Mortimer A, Marr N, Karim MY. Lupus; 2019 May; 28(6):713-721. PubMed ID: 31046570 [Abstract] [Full Text] [Related]
7. Longitudinal assessment of monocyte chemoattractant protein-1 in lupus nephritis as a biomarker of disease activity. Gupta R, Yadav A, Aggarwal A. Clin Rheumatol; 2016 Nov; 35(11):2707-2714. PubMed ID: 27624649 [Abstract] [Full Text] [Related]
9. Serum and urine TNF-like weak inducer of apoptosis, monocyte chemoattractant protein-1 and neutrophil gelatinase-associated lipocalin as biomarkers of disease activity in patients with systemic lupus erythematosus. Mirioglu S, Cinar S, Yazici H, Ozluk Y, Kilicaslan I, Gul A, Ocal L, Inanc M, Artim-Esen B. Lupus; 2020 Apr; 29(4):379-388. PubMed ID: 32041504 [Abstract] [Full Text] [Related]
10. Urinary TWEAK as a biomarker of lupus nephritis: a multicenter cohort study. Schwartz N, Rubinstein T, Burkly LC, Collins CE, Blanco I, Su L, Hojaili B, Mackay M, Aranow C, Stohl W, Rovin BH, Michaelson JS, Putterman C. Arthritis Res Ther; 2009 Apr; 11(5):R143. PubMed ID: 19785730 [Abstract] [Full Text] [Related]
11. Monocyte chemoattractant-1 as a urinary biomarker for the diagnosis of activity of lupus nephritis in Brazilian patients. Rosa RF, Takei K, Araújo NC, Loduca SM, Szajubok JC, Chahade WH. J Rheumatol; 2012 Oct; 39(10):1948-54. PubMed ID: 22942263 [Abstract] [Full Text] [Related]
12. Urinary TWEAK level as a marker of lupus nephritis activity in 46 cases. Xuejing Z, Jiazhen T, Jun L, Xiangqing X, Shuguang Y, Fuyou L. J Biomed Biotechnol; 2012 Oct; 2012():359647. PubMed ID: 22719208 [Abstract] [Full Text] [Related]
13. Diagnostic value of progranulin in patients with lupus nephritis and its correlation with disease activity. Wu J, Wei L, Wang W, Zhang X, Chen L, Lin C. Rheumatol Int; 2016 Jun; 36(6):759-67. PubMed ID: 26968845 [Abstract] [Full Text] [Related]
14. Urinary neutrophil gelatinase-associated lipocalin and monocyte chemoattractant protein 1 as biomarkers for lupus nephritis in Colombian SLE patients. Gómez-Puerta JA, Ortiz-Reyes B, Urrego T, Vanegas-García AL, Muñoz CH, González LA, Cervera R, Vásquez G. Lupus; 2018 Apr; 27(4):637-646. PubMed ID: 29073812 [Abstract] [Full Text] [Related]
15. Urinary MCP-1 as diagnostic and prognostic marker in patients with lupus nephritis flare. Singh RG, Usha, Rathore SS, Behura SK, Singh NK. Lupus; 2012 Oct; 21(11):1214-8. PubMed ID: 22759858 [Abstract] [Full Text] [Related]
16. Serum uric acid as a predictor for nephritis in Egyptian patients with systemic lupus erythematosus. Hafez EA, Hassan SAE, Teama MAM, Badr FM. Lupus; 2021 Mar; 30(3):378-384. PubMed ID: 33323012 [Abstract] [Full Text] [Related]
17. Urinary TWEAK and the activity of lupus nephritis. Schwartz N, Su L, Burkly LC, Mackay M, Aranow C, Kollaros M, Michaelson JS, Rovin B, Putterman C. J Autoimmun; 2006 Dec; 27(4):242-50. PubMed ID: 17257812 [Abstract] [Full Text] [Related]
18. Urinary CXCL-10/IP-10 and MCP-1 as markers to assess activity of lupus nephritis. Abujam B, Cheekatla S, Aggarwal A. Lupus; 2013 May; 22(6):614-23. PubMed ID: 23629827 [Abstract] [Full Text] [Related]
19. International validation of a urinary biomarker panel for identification of active lupus nephritis in children. Smith EM, Jorgensen AL, Midgley A, Oni L, Goilav B, Putterman C, Wahezi D, Rubinstein T, Ekdawy D, Corkhill R, Jones CA, Marks SD, Newland P, Pilkington C, Tullus K, Beresford MW. Pediatr Nephrol; 2017 Feb; 32(2):283-295. PubMed ID: 27590021 [Abstract] [Full Text] [Related]
20. Association of noninvasively measured renal protein biomarkers with histologic features of lupus nephritis. Brunner HI, Bennett MR, Mina R, Suzuki M, Petri M, Kiani AN, Pendl J, Witte D, Ying J, Rovin BH, Devarajan P. Arthritis Rheum; 2012 Aug; 64(8):2687-97. PubMed ID: 22328173 [Abstract] [Full Text] [Related] Page: [Next] [New Search]